Codexis Company Description

Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.

The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route.

It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Codexis, Inc.

Country	United States
Founded	2002
Industry	Biological Products, Except Diagnostic Substances
Employees	188
CEO	Alison Moore

Contact Details

Address: 200 Penobscot Drive Redwood City, Delaware 94063 United States
Phone	650 421 8100
Website	codexis.com

Stock Details

Ticker Symbol	4QK
Exchange	Frankfurt Stock Exchange
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	2836

Key Executives

Name	Position
Alison Moore	Chief Executive Officer
Georgia Erbez	Chief Financial Officer
Carrie McKim	Head of Investor Relations